Compare SYK & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SYK | MDT |
|---|---|---|
| Founded | 1941 | 1949 |
| Country | United States | Ireland |
| Employees | 56000 | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.0B | 131.9B |
| IPO Year | 1994 | 2014 |
| Metric | SYK | MDT |
|---|---|---|
| Price | $331.58 | $86.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 20 |
| Target Price | ★ $429.42 | $108.89 |
| AVG Volume (30 Days) | 2.0M | ★ 7.2M |
| Earning Date | 04-30-2026 | 05-20-2026 |
| Dividend Yield | 1.06% | ★ 3.28% |
| EPS Growth | 8.25 | ★ 30.80 |
| EPS | ★ 8.40 | 2.76 |
| Revenue | $25,116,000,000.00 | ★ $33,537,000,000.00 |
| Revenue This Year | $9.86 | $8.91 |
| Revenue Next Year | $8.39 | $6.71 |
| P/E Ratio | $39.49 | ★ $31.38 |
| Revenue Growth | ★ 11.16 | 3.62 |
| 52 Week Low | $319.32 | $79.55 |
| 52 Week High | $404.87 | $106.33 |
| Indicator | SYK | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 37.08 | 34.72 |
| Support Level | $328.23 | $85.60 |
| Resistance Level | $375.26 | $88.98 |
| Average True Range (ATR) | 8.49 | 1.53 |
| MACD | -0.33 | 0.25 |
| Stochastic Oscillator | 33.65 | 33.30 |
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.